Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Luikart

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Noninvasive monitoring of infection and rejection after lung transplantationIwijn De Vlaminck, Lance Martin, Michael Kertesz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
Circulation|July 19, 2023
Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart StudyKiran K Khush, Darren Malinoski, Helen Luikart, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2024
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of diseaseMichael B Keller, David Newman, Muhtadi Alnababteh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunctionMuhtadi Alnababteh, Junfeng Sun, Rohan Meda, et al.
Journal of the American College of Cardiology|June 10, 2017
Angiotensin-Converting Enzyme Inhibition Early After Heart TransplantationWilliam F Fearon, Kozo Okada, Jon A Kobashigawa, et al.
JACC. Heart Failure|January 20, 2024
Donor Electrocardiogram Associations With Cardiac Dysfunction, Heart Transplant Use, and Survival: The Donor Heart StudyNatalie Tapaskar, Brian Wayda, Darren Malinoski, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Transplantation Direct|July 2, 2024
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort StudyMichael B Keller, Junfeng Sun, Muhtadi Alnababteh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
Noninvasive monitoring of infection and rejection after lung transplantationIwijn De Vlaminck, Lance Martin, Michael Kertesz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 2, 2023
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or deathMichael Keller, Song Yang, Lucia Ponor, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 5, 2021
Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD)Michael Keller, Errol Bush, Joshua M Diamond, et al.
Circulation|July 19, 2023
Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart StudyKiran K Khush, Darren Malinoski, Helen Luikart, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 5, 2024
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of diseaseMichael B Keller, David Newman, Muhtadi Alnababteh, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 24, 2022
Comparison of donor-derived cell-free DNA between single versus double lung transplant recipientsMichael B Keller, Rohan Meda, Sheng Fu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 28, 2025
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunctionMuhtadi Alnababteh, Junfeng Sun, Rohan Meda, et al.
Journal of the American College of Cardiology|June 10, 2017
Angiotensin-Converting Enzyme Inhibition Early After Heart TransplantationWilliam F Fearon, Kozo Okada, Jon A Kobashigawa, et al.
JACC. Heart Failure|January 20, 2024
Donor Electrocardiogram Associations With Cardiac Dysfunction, Heart Transplant Use, and Survival: The Donor Heart StudyNatalie Tapaskar, Brian Wayda, Darren Malinoski, et al.
Pageof 8